Evidence map›Paper›PMID 24951035›Full record

ArticleJournal of neuroinflammation2014

Neonatal cytokines and chemokines and risk of Autism Spectrum Disorder: the Early Markers for Autism (EMA) study: a case-control study.

Ousseny Zerbo, Cathleen Yoshida, Judith K Grether, Judy Van de Water, Paul Ashwood, Gerald N Delorenze, Robin L Hansen, Marty Kharrazi, Lisa A Croen

Open access · goldAbstract read
In one paragraph

Article in Journal of neuroinflammation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 1 synthesis or guideline pooled it, 115 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Neuroinflammation and autism: what have we learned so far?International journal of developmental disabilities · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Air Pollution during Pregnancy and Childhood Autism Spectrum Disorder in Taiwan.International journal of environmental research and public health · 2021
    Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 1 country.

Ousseny ZerboDivision of Research, Kaiser Permanente Northern California, Oakland, CA 94612, USA. ousseny.x.zerbo@kp.org.
Cathleen Yoshida
Judith K Grether
Judy Van de Water
Paul Ashwood
Gerald N Delorenze
Robin L Hansen
Marty Kharrazi
Lisa A Croen
Kaiser Permanente · USCalifornia Department of Public Health · USUniversity of California, Davis · USUniversity of California Davis Medical Center · USUniversity of the Pacific · US

Funding

Prenatal and Neonatal Biologic Markers for AutismR01MH072565 · NIMH · KAISER FOUNDATION RESEARCH INSTITUTE · PI CROEN, LISA A · 2004 to 2006
$1.0M
NIEHS NIH HHS 3R01ES016669NIMH NIH HHS 5R01MH072565
6 · The paper itself

Abstract

backgroundBiologic markers of infection and inflammation have been associated with Autism Spectrum Disorders (ASD) but prior studies have largely relied on specimens taken after clinical diagnosis. Research on potential biologic markers early in neurodevelopment is required to evaluate possible causal pathways and screening profiles.

objectiveTo investigate levels of cytokines and chemokines in newborn blood specimens as possible early biologic markers for autism.

methodsWe conducted a population-based case-control study nested within the cohort of infants born from July 2000 to September 2001 to women who participated in the prenatal screening program in Orange County, California, USA. The study population included children ascertained from the California Department of Developmental Services with Autism Spectrum Disorder (ASD, n = 84), or developmental delay but not ASD (DD, n = 49), and general population controls randomly sampled from the birth certificate files and frequency matched to ASD cases on sex, birth month and birth year (GP, n = 159). Cytokine and chemokine concentrations were measured in archived neonatal blood specimens collected for routine newborn screening.

resultsCytokines were not detected in the vast majority of newborn samples regardless of case or control status. However, the chemokine monocyte chemotactic protein-1 (MCP-1) was elevated and the chemokine Regulated upon Activation Normal T-Cell Expressed and Secreted (RANTES) was decreased in ASD cases compared to GP controls. The chemokines macrophage inflammatory protein-1alpha (MIP-1α) and RANTES were decreased in children with DD compared to GP controls.

conclusionMeasurement of immune system function in the first few days of life may aid in the early identification of abnormal neurodevelopment and shed light on the biologic mechanisms underlying normal neurodevelopment.

Indexed as

Early DiagnosisCase-Control StudiesChild Development Disorders, PervasiveCytokinesDevelopmental DisabilitiesFemaleHumansInfant, NewbornMaleRetrospective StudiesCytokines

Identifiers

PMID24951035
PMCPMC4080514
OpenAlexW2154188802

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.